The increasing spread of carbapenem-resistant Klebsiella pneumoniae represents a serious threat to public health and a major concern for clinicians. In K. pneumoniae, KPC is the most important determinant of carbapenem resistance owing to its distribution worldwide and to the high mortality rates associated with infections due to KPC-producing K. pneumoniae (KPC-Kp) strains
Gaibani, P., Ambretti, S., Tamburini, M.V., Vecchio Nepita, E., Re, M.C. (2018). Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 12, 169-170 [10.1016/j.jgar.2018.01.016].
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates
Gaibani, Paolo
;Ambretti, Simone;Tamburini, Maria Vittoria;Re, Maria Carla
2018
Abstract
The increasing spread of carbapenem-resistant Klebsiella pneumoniae represents a serious threat to public health and a major concern for clinicians. In K. pneumoniae, KPC is the most important determinant of carbapenem resistance owing to its distribution worldwide and to the high mortality rates associated with infections due to KPC-producing K. pneumoniae (KPC-Kp) strainsI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
